Identification of (ultra-)rare candidate functional promoter mutations in cancer using sequence-based deep learning models
The identification of non-coding somatic cancer-driver mutations remains challenging due to difficulties in interpreting rare and ultra-rare variants. We hypothesized that sequence-based models can be used to systematically prioritize such mutations for their functional relevance. Here, we developed a comp...